In Vitro Activities of Tigecycline and Eight Other Antimicrobials against Different <i>Nocardia</i> Species Identified by Molecular Methods

Emilia Cercenado, Mercedes Marín, Mónica Sánchez-Martínez, Óscar Cuevas, José Martínez-Alarcón, Emilio Bouza

Antimicrobial Agents and Chemotherapy · 2006 · 91 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

The in vitro activities of tigecycline and other antimicrobials against 51 isolates of Nocardia spp. were evaluated. MIC(90)s and MIC ranges were as follows: tigecycline, 4 and < or =0.06 to 8 mg/liter, respectively; minocycline, 2 and < or =0.06 to 2 mg/liter, respectively; linezolid, 1 and < or =0.06 to 2 mg/liter, respectively; moxifloxacin, 2 and < or =0.06 to >64 mg/liter, respectively; ertapenem, 32 and < or =0.06->64 mg/liter, respectively; imipenem, 2 and < or =0.06 to >64 mg/liter, respectively; meropenem, 8 and < or =0.06 to >64 mg/liter, respectively; amikacin, 1 and < or =0.06 to 32 mg/liter, respectively; and trimethoprim-sulfamethoxazole, 1/19 and < or =0.5/9.5 to >2/38 mg/liter, respectively.

References

16